Cover Image

Global Burden of Gallbladder Cancer Attributable to Modifiable Risk Factors

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Daniele Piovani, Georgios K. Nikolopoulos, Gisella Figlioli, Andreas G. Tsantes, Stefanos Bonovas
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Alcohol‐Attributable Cancer: Update From the Global Burden of Disease 2021 Study
by: Pojsakorn Danpanichkul, et al.
Published: (2025)

Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021
by: Chunlong Liu, et al.
Published: (2025)

Editorial: Tumour Burden Score and Extrahepatic Progression After TACE —Refining Risk Stratification Beyond the Liver
by: Chien‐Wei Su
Published: (2026)

The Prevalence and Risk Factors for at‐Risk MASH and Advanced Liver Fibrosis in People With Metabolic Risk Factors in Primary Care
by: Leon A. Adams, et al.
Published: (2026)

Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study
by: Fleur Veldman, et al.
Published: (2026)

Letter: Diet to Modify Risk of IBD—More Plants and Less Processed Food?
by: Alice S. Day, et al.
Published: (2025)

Cohort Study: Long‐Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients
by: Mohamed H. Eldesouki, et al.
Published: (2026)

Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
by: Pei‐Chien Tsai, et al.
Published: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease
by: Marco Vincenzo Lenti, et al.
Published: (2025)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
by: Mushfiqur R. Siddique, et al.
Published: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
by: Suprabhat Giri, et al.
Published: (2025)

Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD , MetALD and ALD
by: Nobuharu Tamaki, et al.
Published: (2025)

Letter: The Hidden Truth of IBD Risk—From Antibiotics to Environmental Factors
by: Xueneng Yang, et al.
Published: (2025)

Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection. Authors' Reply
by: Elisa Pinto, et al.
Published: (2026)

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure
by: Charlotte Mouliade, et al.
Published: (2025)

Letter: Enhancing Risk‐Adapted Colorectal Cancer Screening for People With Diabetes—Authors' Reply
by: Teresa Seum, et al.
Published: (2025)

Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
by: Saqr Alsakarneh, et al.
Published: (2025)

Editorial: GLP‐1 receptor agonists in inflammatory bowel disease—Is it time?
by: Konstantinos Arvanitakis, et al.
Published: (2024)

Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome
by: Andrea Shin, et al.
Published: (2025)

Editorial: MetALD and Risk of Gastrointestinal Cancer—What Can We Learn From Japan?
by: Hannes Hagström, et al.
Published: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’
by: James Turvill
Published: (2025)

Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia
by: Amnon Sonnenberg, et al.
Published: (2025)

Editorial: Disentangling Early‐Life Antibiotics and Infections as Risk Factors for the Development of Childhood IBD
by: Katherine L. Stone, et al.
Published: (2024)

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
by: Michelle Spaan, et al.
Published: (2025)

Correction to ‘Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon’
Published: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’. Authors' Reply
by: Hermann Brenner, et al.
Published: (2025)

Letter: H. pylori Infection May Constitute a Risk Factor for Reflux Disease and Colonic Neoplasia
by: Jannis Kountouras, et al.
Published: (2025)

Letter on ‘Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis’—Authors' Reply
by: Francisco Idalsoaga, et al.
Published: (2025)

Editorial: M et ALD and Risk of Gastrointestinal Cancer—What Can We Learn From Japan? Authors' Reply
by: Nobuharu Tamaki, et al.
Published: (2025)

Risk Factors for Liver Disease Cluster Geographically: A Precision Public Health Analysis of a UK City
by: R. Parker, et al.
Published: (2025)

Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis?
by: Alessandro Granito, et al.
Published: (2026)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
by: Alexandra Hickey, et al.
Published: (2025)

Letter: Antiviral Prophylaxis Mitigates HBV Reactivation Risk During Cancer Immunotherapy: Unresolved Challenges and Future Directions—Authors' Reply
by: Landon Long Chan, et al.
Published: (2025)

Editorial: Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab for Hepatocellular Carcinoma—Don't Ignore the Risk Factors! Authors' Reply
by: Jonggi Choi
Published: (2025)

PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort Study
by: Daniel Q. Huang, et al.
Published: (2026)

Editorial: Targeting Urgency in IBD —A Historical Divide
by: Daniele Noviello, et al.
Published: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply
by: Monica E. W. Derks, et al.
Published: (2025)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story? Authors' Reply
by: Sanjay K. Murthy
Published: (2026)

Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply
by: E. Coss‐Adame, et al.
Published: (2026)

Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply
by: Matthias Lenfant, et al.
Published: (2024)